BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29735552)

  • 21. Multi-locus HLA class I and II allele and haplotype associations with follicular lymphoma.
    Skibola CF; Akers NK; Conde L; Ladner M; Hawbecker SK; Cohen F; Ribas F; Erlich HA; Goodridge D; Trachtenberg EA; Smith MT; Bracci PM
    Tissue Antigens; 2012 Apr; 79(4):279-86. PubMed ID: 22296171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").
    Engels EA; Parsons R; Besson C; Morton LM; Enewold L; Ricker W; Yanik EL; Arem H; Austin AA; Pfeiffer RM
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1105-13. PubMed ID: 27197296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
    Lu Y; Abdou AM; Cerhan JR; Morton LM; Severson RK; Davis S; Cozen W; Rothman N; Bernstein L; Chanock S; Hartge P; Wang SS
    ScientificWorldJournal; 2011; 11():2062-70. PubMed ID: 22125456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemia.
    Hosking FJ; Leslie S; Dilthey A; Moutsianas L; Wang Y; Dobbins SE; Papaemmanuil E; Sheridan E; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Taylor M; Greaves M; McVean G; Houlston RS
    Blood; 2011 Feb; 117(5):1633-40. PubMed ID: 21059899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
    Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
    Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study.
    Kleinstern G; Camp NJ; Berndt SI; Birmann BM; Nieters A; Bracci PM; McKay JD; Ghesquières H; Lan Q; Hjalgrim H; Benavente Y; Monnereau A; Wang SS; Zhang Y; Purdue MP; Zeleniuch-Jacquotte A; Giles GG; Vermeulen R; Cocco P; Albanes D; Teras LR; Brooks-Wilson AR; Vajdic CM; Kane E; Caporaso NE; Smedby KE; Salles G; Vijai J; Chanock SJ; Skibola CF; Rothman N; Slager SL; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):1074-1078. PubMed ID: 32108027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between HLA class II polymorphisms and somatic deletions in testicular B cell lymphomas of Dutch patients.
    Riemersma SA; Jordanova ES; Haasnoot GW; Drabbels J; Schuuring E; Schreuder GM; Kluin PM
    Hum Immunol; 2006; 67(4-5):303-10. PubMed ID: 16720210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
    Din L; Sheikh M; Kosaraju N; Smedby KE; Bernatsky S; Berndt SI; Skibola CF; Nieters A; Wang S; McKay JD; Cocco P; Maynadié M; Foretová L; Staines A; Mack TM; de Sanjosé S; Vyse TJ; Padyukov L; Monnereau A; Arslan AA; Moore A; Brooks-Wilson AR; Novak AJ; Glimelius B; Birmann BM; Link BK; Stewart C; Vajdic CM; Haioun C; Magnani C; Conti DV; Cox DG; Casabonne D; Albanes D; Kane E; Roman E; Muzi G; Salles G; Giles GG; Adami HO; Ghesquières H; De Vivo I; Clavel J; Cerhan JR; Spinelli JJ; Hofmann J; Vijai J; Curtin K; Costenbader KH; Onel K; Offit K; Teras LR; Morton L; Conde L; Miligi L; Melbye M; Ennas MG; Liebow M; Purdue MP; Glenn M; Southey MC; Din M; Rothman N; Camp NJ; Wong Doo N; Becker N; Pradhan N; Bracci PM; Boffetta P; Vineis P; Brennan P; Kraft P; Lan Q; Severson RK; Vermeulen RCH; Milne RL; Kaaks R; Travis RC; Weinstein SJ; Chanock SJ; Ansell SM; Slager SL; Zheng T; Zhang Y; Benavente Y; Taub Z; Madireddy L; Gourraud PA; Oksenberg JR; Cozen W; Hjalgrim H; Khankhanian P
    Genet Epidemiol; 2019 Oct; 43(7):844-863. PubMed ID: 31407831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of HLA alleles with non-Hodgkin's lymphoma in Korean population.
    Choi HB; Roh SY; Choi EJ; Yoon HY; Kim SY; Hong YS; Kim DW; Kim TG
    Int J Hematol; 2008 Mar; 87(2):203-209. PubMed ID: 18301962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.
    Morton LM; Wang SS; Cozen W; Linet MS; Chatterjee N; Davis S; Severson RK; Colt JS; Vasef MA; Rothman N; Blair A; Bernstein L; Cross AJ; De Roos AJ; Engels EA; Hein DW; Hill DA; Kelemen LE; Lim U; Lynch CF; Schenk M; Wacholder S; Ward MH; Hoar Zahm S; Chanock SJ; Cerhan JR; Hartge P
    Blood; 2008 Dec; 112(13):5150-60. PubMed ID: 18796628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A search for overlapping genetic susceptibility loci between non-Hodgkin lymphoma and autoimmune diseases.
    Conde L; Bracci PM; Halperin E; Skibola CF
    Genomics; 2011 Jul; 98(1):9-14. PubMed ID: 21439368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary study of HLA class II alleles in Thai patients with non Hodgkin's lymphoma.
    Nathalang O; Tatsumi N; Hino M; Yamane T; Prayoonwiwat W; Suwanasophon C; Sriphaisal T
    Osaka City Med J; 1997 Dec; 43(2):253-8. PubMed ID: 9540346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1.
    Wang SS; Lu Y; Rothman N; Abdou AM; Cerhan JR; De Roos A; Davis S; Severson RK; Cozen W; Chanock SJ; Bernstein L; Morton LM; Hartge P
    PLoS One; 2011; 6(11):e26949. PubMed ID: 22096508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically Determined Height and Risk of Non-hodgkin Lymphoma.
    Moore A; Kane E; Wang Z; Panagiotou OA; Teras LR; Monnereau A; Wong Doo N; Machiela MJ; Skibola CF; Slager SL; Salles G; Camp NJ; Bracci PM; Nieters A; Vermeulen RCH; Vijai J; Smedby KE; Zhang Y; Vajdic CM; Cozen W; Spinelli JJ; Hjalgrim H; Giles GG; Link BK; Clavel J; Arslan AA; Purdue MP; Tinker LF; Albanes D; Ferri GM; Habermann TM; Adami HO; Becker N; Benavente Y; Bisanzi S; Boffetta P; Brennan P; Brooks-Wilson AR; Canzian F; Conde L; Cox DG; Curtin K; Foretova L; Gapstur SM; Ghesquières H; Glenn M; Glimelius B; Jackson RD; Lan Q; Liebow M; Maynadie M; McKay J; Melbye M; Miligi L; Milne RL; Molina TJ; Morton LM; North KE; Offit K; Padoan M; Patel AV; Piro S; Ravichandran V; Riboli E; de Sanjose S; Severson RK; Southey MC; Staines A; Stewart C; Travis RC; Weiderpass E; Weinstein S; Zheng T; Chanock SJ; Chatterjee N; Rothman N; Birmann BM; Cerhan JR; Berndt SI
    Front Oncol; 2019; 9():1539. PubMed ID: 32064237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imputation of class I and II HLA loci using high-density SNPs from ImmunoChip and their associations with Kawasaki disease in family-based study.
    Shrestha S; Wiener HW; Aissani B; Shendre A; Tang J; Portman MA
    Int J Immunogenet; 2015 Jun; 42(3):140-6. PubMed ID: 25809546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
    Charbonneau B; Wang AH; Maurer MJ; Asmann YW; Zent CS; Link BK; Ansell SM; Weiner GJ; Ozsan N; Feldman AL; Witzig TE; Cunningham JM; Dogan A; Habermann TM; Slager SL; Novak AJ; Cerhan JR
    Cancer Immunol Immunother; 2013 Sep; 62(9):1475-84. PubMed ID: 23812490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.
    Johnson PC; McAulay KA; Montgomery D; Lake A; Shield L; Gallagher A; Little AM; Shah A; Marsh SG; Taylor GM; Jarrett RF
    Int J Cancer; 2015 Sep; 137(5):1066-75. PubMed ID: 25648508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outdoor artificial light at night and risk of non-Hodgkin lymphoma among women in the California Teachers Study cohort.
    Zhong C; Franklin M; Wiemels J; McKean-Cowdin R; Chung NT; Benbow J; Wang SS; Lacey JV; Longcore T
    Cancer Epidemiol; 2020 Dec; 69():101811. PubMed ID: 33002844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-A*26 and susceptility of iranian patients with non-Hodgkin lymphoma.
    Sayad A; Akbari MT; Mehdizadeh M; Taheri M; Hajifathali A
    Iran J Immunol; 2014 Dec; 11(4):269-74. PubMed ID: 25549594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
    Morton LM; Curtis RE; Linet MS; Bluhm EC; Tucker MA; Caporaso N; Ries LA; Fraumeni JF
    J Clin Oncol; 2010 Nov; 28(33):4935-44. PubMed ID: 20940199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.